Related Experiment Video

Updated: Jul 17, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

9.9K

Editorial: Decoding ACLF-Sub-Phenotyping to Advance Precision Medicine in Acute-On-Chronic Liver Failure

Amy Sangam1, Banwari Agarwal1,2, Rohit Saha1

  • 1Intensive Care Unit, Royal Free Hospital, London, UK.

Alimentary Pharmacology & Therapeutics
|October 29, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Investigating Hepatic Adaptations and Prediabetic Progression in Liver Diseases
06:21

Author Spotlight: Investigating Hepatic Adaptations and Prediabetic Progression in Liver Diseases

Published on: October 6, 2023

1.7K
Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model
06:45

Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model

Published on: January 19, 2024

529

Related Experiment Videos

Last Updated: Jul 17, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

9.9K
Author Spotlight: Investigating Hepatic Adaptations and Prediabetic Progression in Liver Diseases
06:21

Author Spotlight: Investigating Hepatic Adaptations and Prediabetic Progression in Liver Diseases

Published on: October 6, 2023

1.7K
Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model
06:45

Author Spotlight: Advancing Liver Regeneration Research through ALPPS Mouse Model

Published on: January 19, 2024

529

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

Articles linked to this work by shared authors, journal, and citation graph.

Use of intracranial pressure monitoring and risk factors for the development of intracranial hypertension in acute liver failure.

Journal of hepatology·2025

Plasma exchange does not improve overall survival in patients with acute liver failure in a real-world cohort.

Journal of hepatology·2024

Non-selective beta-blocker is associated with reduced mortality in critically ill patients with cirrhosis: A real-world study.

Alimentary pharmacology & therapeutics·2024

Improving 1-Year Mortality Following Intensive Care Unit Admission in Adults with HIV: A 20-Year Observational Study.

Journal of intensive care medicine·2024

Novel Therapeutic Approaches in Treatment of Acute-on-Chronic Liver Failure.

Seminars in liver disease·2023

Nebulized Recombinant Tissue Plasminogen Activator (rt-PA) for Acute COVID-19-Induced Respiratory Failure: An Exploratory Proof-of-Concept Trial.

Journal of clinical medicine·2023

Clinical Trial: Intensive Supervised Nutritional Therapy Versus Guideline-Based Nutritional Advice for Sarcopenia in Decompensated Cirrhosis-A Randomised Controlled Trial.

Alimentary pharmacology & therapeutics·2026

Meta-Analysis: Enhanced Liver Fibrosis (ELF) Test for Identifying Significant Fibrosis, Advanced Fibrosis, and Cirrhosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Alimentary pharmacology & therapeutics·2026

Bowel Preparation in Quality Guidelines and Clinical Practice.

Alimentary pharmacology & therapeutics·2026

Modern Bowel Preparations, Clinical Evidence and Practical Advantages.

Alimentary pharmacology & therapeutics·2026

The Clinical Importance of Adequate Bowel Preparation.

Alimentary pharmacology & therapeutics·2026

Anti-Integrin αvβ6 Autoantibodies Distinguish Ulcerative Colitis From Crohn's Disease With High Diagnostic Accuracy and Outperform ANCA and ASCA Status: A Prospective Cross-Sectional Study.

Alimentary pharmacology & therapeutics·2026

Podocan-Like Protein 1 as a Novel Contributor to HIV-Associated Pulmonary Vascular Disease.

Journal of the American Heart Association·2026

Progress in the Design and Clinical Application of Probes for Fluorescence-Guided Laparoscopic Surgery.

Chemical & biomedical imaging·2026

Cover Feature: Advances in Polyethyleneimine-Derived Nanoformulations (Small Sci. 8/2026).

Small science·2026

Multi-omics-driven precision medicine.

iMeta·2026

Deprescribing and Anti-CGRP preventive therapy in medication-overuse headache associated with migraine: pathophysiological rationale and single-center real world evidence.

Frontiers in drug safety and regulation·2026

Human histone fragments display antibacterial properties against Pseudomonas aeruginosa.

Frontiers in immunology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us